Ticker > Company >

GKB Ophthalmics share price

GKB Ophthalmics Ltd.

NSE: GKB BSE: 533212 SECTOR: Medical Equipment/Supplies/Accessories  14.27 K   5   1

82.10
+0.91 (1.12%)
BSE: 01 Aug 04:01 PM

Price Summary

Today's High

₹ 84.9

Today's Low

₹ 75.5

52 Week High

₹ 131.75

52 Week Low

₹ 59

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

41.38 Cr.

Enterprise Value

58.58 Cr.

No. of Shares

0.5 Cr.

P/E

0

P/B

2.34

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  35.06

CASH

0.89 Cr.

DEBT

18.09 Cr.

Promoter Holding

51.06 %

EPS (TTM)

₹  -12.12

Sales Growth

5.03%

ROE

-29.32 %

ROCE

-11.72%

Profit Growth

-78.78 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year5.03%
3 Year6.58%
5 Year5.08%

Profit Growth

1 Year-78.78%
3 Year-186.35%
5 Year-11.73%

ROE%

1 Year-29.32%
3 Year-17.51%
5 Year-13.21%

ROCE %

1 Year-11.72%
3 Year-6.79%
5 Year-4.94%

Debt/Equity

1.0233

Price to Cash Flow

-8.22

Interest Cover Ratio

-2.1994

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 51.06 0.00
Mar 2025 50.99 0.00
Dec 2024 50.98 0.00
Sep 2024 50.95 0.00
Jun 2024 50.95 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of -0.435900000000004 days.
  • The company has a high promoter holding of 51.06%.

 Limitations

  • The company has shown a poor profit growth of -186.346233885763% for the Past 3 years.
  • The company has shown a poor revenue growth of 6.58302678633622% for the Past 3 years.
  • Company has a poor ROE of -17.5129666666667% over the past 3 years.
  • Company has a poor ROCE of -6.78693333333333% over the past 3 years
  • Company has low Interest coverage ratio of -2.1994.
  • Company has contingent liabilities of 17.8889 Cr.
  • Company has negative cash flow from operations of -5.0368.
  • The company has a low EBITDA margin of -4.59982899050954% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 7.36 8.62 8.26 7.45 8.43
Total Expenditure 7.76 9.05 9.3 8.27 9.61
Operating Profit -0.41 -0.43 -1.04 -0.82 -1.19
Other Income 0.2 0.09 0.06 1.81 0.01
Interest 0.48 0.41 0.4 0.48 0.6
Depreciation 0.64 0.65 0.66 0.67 0.66
Exceptional Items 0 0 0 0 0
Profit Before Tax -1.33 -1.4 -2.04 -0.16 -2.44
Tax 0.04 0.01 0.01 0.01 0.04
Profit After Tax -1.37 -1.41 -2.05 -0.17 -2.48
Adjusted EPS (Rs) -2.72 -2.79 -4.07 -0.33 -4.92

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 21.34 27.05 27.73 31.18 32.75
Total Expenditure 21.92 27.49 28.83 32.45 36.23
Operating Profit -0.57 -0.45 -1.1 -1.27 -3.48
Other Income 3.34 1.96 2.09 2.08 1.97
Interest 1.34 1.34 1.5 1.59 1.89
Depreciation 2.99 2.49 2.54 2.59 2.64
Exceptional Items -0.72 0 0 0 0
Profit Before Tax -2.29 -2.31 -3.04 -3.38 -6.04
Tax -0.18 0 -0.16 0.04 0.07
Net Profit -2.11 -2.31 -2.88 -3.42 -6.11
Adjusted EPS (Rs.) -4.18 -4.58 -5.72 -6.78 -12.12

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 5.04 5.04 5.04 5.04 5.04
Total Reserves 27.73 25.36 22.48 18.95 12.63
Borrowings 1 1.62 1.17 0.64 7.25
Other N/C liabilities 5.72 6.63 6.62 6.67 6.22
Current liabilities 21.11 18.98 17.58 20.83 22.08
Total Liabilities 60.6 57.63 52.89 52.13 53.22
Assets
Net Block 22.28 21.27 17.28 15.89 14.44
Capital WIP 1.23 3.29 3.82 3.78 3.78
Intangible WIP 0 0 0 0 0
Investments 11.9 11.9 11.9 11.9 11.9
Loans & Advances 6.67 7.08 6.46 6.3 6.43
Other N/C Assets 0.04 0.03 0 0 0
Current Assets 18.48 14.06 13.43 14.26 16.68
Total Assets 60.6 57.63 52.89 52.13 53.22
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -2.29 -2.31 -3.04 -3.38 -6.04
Adjustment 2.13 2.25 2.34 2.23 2.79
Changes in Assets & Liabilities 2.27 2.4 -0.41 2.52 -1.76
Tax Paid 0 -0.01 -0.04 -0.01 -0.03
Operating Cash Flow 2.11 2.33 -1.14 1.36 -5.04
Investing Cash Flow -11.52 -0.83 2.4 0.37 -0.16
Financing Cash Flow 0.61 -1.5 -2.03 -1.74 5.12
Net Cash Flow -8.8 0 -0.78 0 -0.07

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 50.95 50.95 50.98 50.99 51.06
gaurav gupta 8.09 8.09 8.09 8.09 8.09
krishna gopal gupta 17.90 17.90 17.91 17.91 17.91
krishnagopal gupta and so... 5.78 5.78 5.81 5.81 5.88
shefali chawla 4.81 4.81 4.81 4.81 4.81
veena gupta 5.97 5.97 5.97 5.97 5.97
vikram gupta 8.39 8.39 8.39 8.39 8.39
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 49.05 49.05 49.02 49.01 48.94
brijendra kumar gupta 4.86 4.86 3.55 3.55 3.55
coeus global opportunitie... 1.79 1.79 1.79 1.79 1.79
dhwaja commodity services... 1.43 1.43 1.43 1.43 1.43
jyotivardhan jaipuria 1.32 1.32 1.32 1.32 1.32
kiran rashmin rughani - 1.09 1.09 1.09 1.01
krishna murari gupta 6.43 6.39 5.54 5.54 5.54
lalit kumar gupta 1.40 1.40 1.40 1.40 1.40
mahendra girdharilal wadh... - 1.00 1.00 1.21 1.21
phani kishore talluri - - 1.03 1.19 1.19
somo vision co. ltd. 3.97 3.97 3.97 3.97 3.97
tanvi jignesh mehta 1.20 1.75 2.10 2.10 2.29
varsha chugh . - - 1.27 1.27 1.27
vijit global securities p... - 1.00 - - -
usha gupta 1.52 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

GKB Ophthalmics informs about annual report 29 Jul, 3:34 PM GKB Ophthalmics informs about press release 2 Jun, 2:05 PM GKB Ophthalmics informs about newspaper cuttings 2 Jun, 12:08 PM GKB Ophthalmics informs about change in contact details of RTA 21 Apr, 9:37 AM GKB Ophthalmics informs about trading window closure 29 Mar, 1:58 PM GKB Ophthalmics submits notice of independent directors meeting 18 Mar, 5:27 PM GKB Ophthalmics informs about newspaper publication 19 Feb, 5:22 PM GKB Ophthalmics - Quaterly Results 13 Feb, 6:34 PM Gkb Ophthalmics informs about updates 2 Jan, 3:01 PM GKB Ophthalmics - Quaterly Results 13 Aug, 6:51 PM GKB Ophthalmics informs about certificate 6 Jul, 10:25 AM GKB Ophthalmics informs about disclosure 30 Mar, 11:26 AM GKB Ophthalmics - Quaterly Results 14 Feb, 6:36 PM Gkb Ophthalmics informs about certificate 17 Jan, 3:41 PM Gkb Ophthalmics informs about AGM minutes 11 Oct, 1:50 PM GKB Ophthalmics informs about compliances-certificate 13 Jul, 4:21 PM GKB Ophthalmics informs about compliance certificate 19 Apr, 5:15 PM Gkb Ophthalmics informs about outcome of directors meeting 13 Mar, 3:26 PM GKB Ophthalmics informs about newspaper publication 17 Feb, 4:27 PM GKB Ophthalmics informs about disclosure of related party transactions 26 Nov, 2:38 PM GKB Ophthalmics informs about newspaper cuttings 16 Aug, 5:05 PM GKB Ophthalmics informs about board meeting 28 Jul, 4:27 PM GKB Ophthalmics informs about disclosure 14 Jun, 4:12 PM Gkb Ophthalmics informs about disclosure 17 May, 4:48 PM Gkb Ophthalmics informs about outcome of director’s meeting 17 Mar, 5:14 PM Gkb Ophthalmics informs about postal ballot notice 11 Mar, 4:38 PM GKB Ophthalmics informs about related party transactions 8 Dec, 11:53 AM GKB Ophthalmics informs about disclosure 6 Sep, 4:01 PM GKB Ophthalmics informs about book closure 6 Sep, 3:59 PM GKB Ophthalmics informs about disclosure 31 Aug, 2:25 PM GKB Ophthalmics informs about newspaper publication 30 Aug, 1:47 PM GKB Ophthalmics informs about prohibition of insider trading 30 Aug, 1:41 PM GKB Ophthalmics informs about newspaper cuttings 14 Jun, 4:34 PM GKB Ophthalmics informs about disclosure 11 Mar, 3:53 PM GKB Ophthalmics informs about disclosure 9 Mar, 4:24 PM GKB Ophthalmics informs about disclosure 8 Mar, 12:11 PM GKB Ophthalmics informs about disclosure 25 Feb, 3:03 PM GKB Ophthalmics informs about disclosure 19 Feb, 12:55 PM GKB Ophthalmics informs about newspaper publication 1 Feb, 10:49 AM GKB Ophthalmics informs about disclosure 1 Jan, 3:57 PM GKB Ophthalmics informs about disclosure 17 Dec, 3:30 PM GKB Ophthalmics informs about outcome of board meeting 16 Dec, 2:15 PM GKB Ophthalmics informs about postal ballot notice 30 Nov, 3:10 PM GKB Ophthalmics informs about proceedings of the 38th AGM 26 Sep, 2:08 PM GKB Ophthalmics informs about company updates 7 Sep, 3:19 PM GKB Ophthalmics informs about newspaper cuttings 11 Aug, 10:19 AM GKB Ophthalmics informs about prohibition of insider trading 17 Jul, 3:36 PM GKB Ophthalmics informs about newspaper publication 12 Jun, 3:41 PM

GKB Ophthalmics Stock Price Analysis and Quick Research Report. Is GKB Ophthalmics an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. GKB Ophthalmics stock price today is Rs 82.1. So, let’s look into GKB Ophthalmics and its performance over the period of time. 

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs -5.0368 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. GKB Ophthalmics has a Debt to Equity ratio of 1.0233 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In GKB Ophthalmics , the EPS growth was -78.7807 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, GKB Ophthalmics has OPM of -10.6221793376367 % which is a bad sign for profitability.
     
  • ROE: GKB Ophthalmics have a poor ROE of -29.3227 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of GKB Ophthalmics is Rs 82.1. One can use valuation calculators of ticker to know if GKB Ophthalmics share price is undervalued or overvalued.
Last Updated on:
Brief about GKB Ophthalmics
X